These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 14738260)
1. Use of intravenous anti-D in patients with refractory and relapsed immune thrombocytopenic purpura. Sajid R; Adil SN; Fadoo Z; Sabir S; Khurshid M J Pak Med Assoc; 2003 Nov; 53(11):537-9. PubMed ID: 14738260 [TBL] [Abstract][Full Text] [Related]
2. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649 [TBL] [Abstract][Full Text] [Related]
4. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura]. Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940 [TBL] [Abstract][Full Text] [Related]
5. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Cooper N; Woloski BM; Fodero EM; Novoa M; Leber M; Beer JH; Bussel JB Blood; 2002 Mar; 99(6):1922-7. PubMed ID: 11877261 [TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Freiberg A; Mauger D Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746 [TBL] [Abstract][Full Text] [Related]
7. Predicting response to splenectomy in children with immune thrombocytopenic purpura. Wood JH; Partrick DA; Hays T; Ziegler MM J Pediatr Surg; 2010 Jan; 45(1):140-4; discussion 144. PubMed ID: 20105594 [TBL] [Abstract][Full Text] [Related]
8. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Bussel JB; Kaufmann CP; Ware RE; Woloski BM Am J Hematol; 2001 May; 67(1):27-33. PubMed ID: 11279654 [TBL] [Abstract][Full Text] [Related]
9. Chronic ITP: analysis of various factors at presentation which predict failure to first line treatment and their response to second line therapy. Syed NN; Adil SN; Sajid R; Usman M; Moiz B; Kakepoto GN; Khurshid M J Pak Med Assoc; 2007 Mar; 57(3):126-9. PubMed ID: 17432016 [TBL] [Abstract][Full Text] [Related]
10. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura. Ramadan KM; El-Agnaf M Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495 [TBL] [Abstract][Full Text] [Related]
12. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. Lowe EJ; Buchanan GR J Pediatr; 2002 Aug; 141(2):253-8. PubMed ID: 12183723 [TBL] [Abstract][Full Text] [Related]